Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Minimal Residual Disease (MRD)145.53M81.32%
Immune Medicine33.43M18.68%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States178.96M100.00%